Markers of coagulation dysfunction and inflammation in diabetic and non-diabetic COVID-19

Seshadri Reddy Varikasuvu1, Saurabh Varshney2, Naveen Dutt3

  • 1Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), Deoghar, Jharkhand, 814152, India. lifeschemistry@live.com.

Insights

Diabetic patients with COVID-19 showed significantly higher levels of inflammatory markers and coagulation dysfunction compared to non-diabetic patients. This suggests increased susceptibility to severe complications in diabetic individuals.

Area of Science:

  • Medical research
  • Infectious diseases
  • Endocrinology

Background:

  • COVID-19 presents diverse clinical manifestations, with a notable impact on coagulation and inflammation.
  • Diabetes mellitus is a known risk factor for severe infections and adverse outcomes.
  • Understanding the interplay between diabetes, COVID-19, and hypercoagulability is crucial for patient management.

Discussion:

  • Diabetic COVID-19 patients exhibited elevated serum ferritin, C-reactive protein, interleukin-6, fibrinogen, and D-dimers.
  • These findings indicate a heightened inflammatory response and pro-thrombotic state in diabetic individuals with COVID-19.
  • The observed differences were statistically significant, suggesting a genuine biological effect.

Key Insights:

  • Diabetic COVID-19 patients experience more severe inflammation and coagulation dysfunction.
  • Markers such as serum ferritin, CRP, IL-6, fibrinogen, and D-dimers are significantly elevated.
  • This heightened inflammatory and hypercoagulable state may predispose diabetic patients to worse COVID-19 outcomes.

Outlook:

  • Further research is warranted to explore the specific mechanisms driving these differences.
  • Investigating targeted therapeutic strategies for diabetic COVID-19 patients is essential.
  • Long-term follow-up studies can elucidate the chronic implications of these findings.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.8K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.2K
Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
983
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.8K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
645
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
217